Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1065 of 1,261
  1. US 7345054

    Heterocyclic inhibitors of ERK2 and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 18, 2008 · Expires Mar 13, 2028

    granted
  2. US 7345060

    Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Mar 18, 2008 · Expires Mar 13, 2028

    granted
  3. US 7344711

    Use of adenoviruses mutated in the VA genes for cancer treatment

    ONCOLYTICS BIOTECH INC. · Granted Mar 18, 2008 · Expires Mar 13, 2028

    granted
  4. US 2008063603

    ULTRASOUND CONTRAST AGENTS AND METHODS OF MAKING AND USING THEM

    BRACCO INT BV [NL] · Granted Mar 13, 2008 · Expires Mar 8, 2028

    granted
  5. US 7342120

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 11, 2008 · Expires Mar 6, 2028

    granted
  6. US 7342105

    Antibody and use thereof

    Takeda Chemical Industries Ltd. · Granted Mar 11, 2008 · Expires Mar 6, 2028

    granted
  7. US 7342101

    Compositions and methods comprising a protective antigen of Coccidiodes immitis

    THE UNIVERSTY OF TEXAS SYSTEM,BOARD OF REGENTS · Granted Mar 11, 2008 · Expires Mar 6, 2028

    granted
  8. US 7341726

    Modified HCV peptide immunogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 11, 2008 · Expires Mar 6, 2028

    granted
  9. US 7341871

    Nucleotide sequences for gene regulation and methods of use thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 11, 2008 · Expires Mar 6, 2028

    granted
  10. US 7342046

    Gossypol co-crystals and the use thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 11, 2008 · Expires Mar 6, 2028

    granted
  11. US 7341993

    Cross-linked glycopeptide—cephalosporin antibiotics

    Theravance, Inc. · Granted Mar 11, 2008 · Expires Mar 6, 2028

    granted
  12. US 7341709

    Compositions for labeling β-amyloid plaques and neurofibrillary tangles

    The Regents of the University of California · Granted Mar 11, 2008 · Expires Mar 6, 2028

    granted
  13. US 7338758

    Compositions and methods for the identification, assessment, prevention and therapy of human cancers

    The Board of Regents of the University of Texas System · Granted Mar 4, 2008 · Expires Feb 28, 2028

    granted
  14. US 7339037

    Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 4, 2008 · Expires Feb 28, 2028

    granted
  15. US 7339064

    Benzimidazole compound crystal

    Takeda Pharmaceutical Company Limited · Granted Mar 4, 2008 · Expires Feb 28, 2028

    granted
  16. US 7338652

    Methods for positron emission imaging with radiolabeled halogenated xanthenes diagnostic agents

    Provectus Pharmatech, Inc. · Granted Mar 4, 2008 · Expires Feb 28, 2028

    granted
  17. US 7338961

    Sphingosine kinase inhibitors

    Apogee Biotechnology Corporation · Granted Mar 4, 2008 · Expires Feb 28, 2028

    granted
  18. US 7338798

    System and method for forming a cardiac muscle construct

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 4, 2008 · Expires Feb 28, 2028

    granted
  19. US 7339023

    Partial peptide mimetics and methods

    Regents of the University of Minnesota · Granted Mar 4, 2008 · Expires Feb 28, 2028

    granted
  20. US 7338807

    Screening assays for compounds that cause apoptosis

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 4, 2008 · Expires Feb 28, 2028

    granted
  21. US 7335646

    Compositions and methods for regulated protein expression in gut

    ENGENE, INC. · Granted Feb 26, 2008 · Expires Feb 21, 2028

    granted
  22. US 7335679

    Wortmannin analogs and methods of using same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Feb 26, 2008 · Expires Feb 21, 2028

    granted
  23. US 7335499

    tRNA synthetase

    Replidyne, Inc. · Granted Feb 26, 2008 · Expires Feb 21, 2028

    granted
  24. US 7335658

    Pyridazine derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Feb 26, 2008 · Expires Feb 21, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.